Red X iconGreen tick iconYellow tick icon

Associate Professor

image alt textBHB MB ChB (Auck) PhD (Edin) MPH FRACP FCSANZ FESC
Email philip.adamson@otago.ac.nz

Current roles

  • Associate Professor – Department of Medicine, University of Otago Christchurch
  • Consultant Interventional Cardiologist – Te Whatu Ora – Waitaha Canterbury and the Christchurch Heart Group
  • Senior Research Fellow – University of Edinburgh

Professional and research interests

  • Coronary artery disease (angina and acute coronary syndrome)
  • Valvular heart disease (aortic stenosis, mitral regurgitation)
  • Stroke prevention (PFO closure, LAA occlusion)
  • Cardiac computed tomography (CT)

Phil works in the Christchurch Heart Institute and is a Consultant Interventional Cardiologist.

His clinical expertise is related to the treatment of coronary and structural heart diseases (coronary stenting, TAVI, PFO closure, etc).

His research focus is the diagnostic and prognostic assessment of cardiovascular disease using circulating and imaging biomarkers, particularly advanced cardiac CT imaging. He currently holds 2 project grants from the Health Research Council of NZ for multicentre trials investigating new approaches to the treatment of acute coronary syndromes. He is also an investigator for new devices being tested as minimally invasive treatments for structural heart disease and stroke prevention.

Outside of work he enjoys anything that gets him into the outdoors – running, hiking, and mountain biking.

Publications

Pons, A., Whalley, G., Wyber, R., Bridgman, P., Stewart, R., Adamson, P., … Coffey, S. (2026). Fatigue is a key contributor to quality of life in heart valve disease and after valve replacement/repair: A qualitative study. Heart, Lung & Circulation. Advance online publication. doi: 10.1016/j.hlc.2025.11.008 Journal - Research Article

Hillis, G. S., Walker, J. S. K., Gilbert, T., Budgeon, C. A., French, J. K., Selvanayagam, J. B., … Troughton, R. W., … Adamson, P. D., … Whalley, G. A., … Stewart, R. A. H. (2026). Rationale for and design of the REsolution of LEft VENTricular thrombus (RELEVENT) Trial. American Heart Journal, 293, 107301. doi: 10.1016/j.ahj.2025.107301 Journal - Research Other

Keys, T., Greer, C., Adamson, P. D., Pickering, J. W., Pilbrow, A. P., Frampton, C., … Troughton, R. W., … Richards, A. M., Pemberton, C. J., & Chew-Harris, J. (2025). Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes. European Heart Journal Open, 5(5), oeaf097. doi: 10.1093/ehjopen/oeaf097 Journal - Research Article

Mahfoud, F., Ukena, C., Adamson, P. D., O'Connor, M., Brooks, M., King, L.-M., … Panikker, S. (2025). Left atrial appendage occlusion using a novel system: Preclinical evaluation and first-in-human experience. JACC: Cardiovascular Interventions, 18(24), 3072-3083. doi: 10.1016/j.jcin.2025.10.002 Journal - Research Article

Williams, M. C., Guimaraes, A. R., Jiang, M., Kwiecinski, J., Weir-McCall, J. R., Adamson, P. D., … Dey, D. (2025). Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial. Open Heart, 12, e003162. doi: 10.1136/openhrt-2025-003162 Journal - Research Article

Back to top